We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

173 hedge funds and large institutions have $834M invested in Cardiovascular Systems, Inc. in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 24

20% more capital invested

Capital invested by funds: $693M → $834M (+$141M)

14% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 57

4% more funds holding

Funds holding: 167173 (+6)

Holders
173
Holders Change
+6
Holders Change %
+3.59%
% of All Funds
2.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
65
Reduced
57
Closed
24
Calls
$1.75M
Puts
Net Calls
+$1.75M
Net Calls Change
+$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$6.15M -$51.2K -2,637 -1%
Ameriprise
27
Ameriprise
Minnesota
$5.27M +$844K +43,463 +23%
Norges Bank
28
Norges Bank
Norway
$5.15M -$1.02M -52,424 -19%
Invesco
29
Invesco
Georgia
$4.71M -$6.13M -315,701 -60%
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$4.41M +$1.68M +86,514 +80%
GKIM
31
GW&K Investment Management
Massachusetts
$4.33M -$25.5K -1,315 -0.7%
Legal & General Group
32
Legal & General Group
United Kingdom
$4.31M -$889K -45,784 -19%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$4.24M +$1.72M +88,376 +89%
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$4.15M +$240K +12,382 +7%
KLC
35
Kent Lake Capital
Nevada
$3.96M +$3.4M +175,000 New
Goldman Sachs
36
Goldman Sachs
New York
$3.73M -$684K -35,250 -18%
Voloridge Investment Management
37
Voloridge Investment Management
Florida
$3.12M +$520K +26,782 +24%
Walleye Capital
38
Walleye Capital
New York
$2.81M -$1.47M -75,691 -38%
Federated Hermes
39
Federated Hermes
Pennsylvania
$2.7M +$2.32M +119,330 New
AG
40
Algert Global
California
$2.42M +$897K +46,215 +76%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$2.38M +$115K +5,901 +6%
TA
42
Teton Advisors
New York
$2.3M
ETC
43
Exchange Traded Concepts
Oklahoma
$2.18M -$1.56M -80,127 -45%
Swiss National Bank
44
Swiss National Bank
Switzerland
$2.17M +$140K +7,200 +8%
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
$2.04M -$195K -10,069 -10%
Allspring Global Investments
46
Allspring Global Investments
North Carolina
$2.02M +$1.5M +77,093 +616%
CCM
47
Cinctive Capital Management
New York
$1.85M +$1.59M +82,000 New
Public Sector Pension Investment Board (PSP Investments)
48
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.72M -$130K -6,690 -8%
SFI
49
Susquehanna Fundamental Investments
Pennsylvania
$1.72M +$1.47M +75,884 New
GCP
50
GSA Capital Partners
United Kingdom
$1.55M +$756K +38,964 +132%

CSII Hedge Fund Activity: Q1 2022 in Review

173 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2022, worth a combined $834M — up 20% from $693M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new CSII positions and 24 closed out — a net gain of 7 holders — while 65 added to existing stakes and 57 trimmed.

The largest buyer was Nuveen, adding an estimated $8.04M. The largest seller was Invesco, cutting an estimated $6.13M.

  • 173 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2022, up from 167 in Q4 2021.
  • Funds reported $834M of Cardiovascular Systems, Inc. stock for Q1 2022, up 20% quarter-over-quarter.
  • 31 funds opened new Cardiovascular Systems, Inc. positions in Q1 2022 and 24 closed out, a net change of +7 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2022 was Nuveen, an estimated $8.04M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2022 was Invesco, an estimated $6.13M sold.

Based on aggregated 13F filings for Q1 2022.